FDA Approves Botox to Treat Chronic Migraines
Injections of Botox Can Relieve Migraine Headache Symptoms for up to 3 Months
Botox Side Effects
The most common adverse reactions reported by patients being treated for chronic migraine have been neck pain and headache, the FDA says.
The FDA also has placed a “boxed warning” on the anti-migraine drug, onabotulinumtoxinA, marketed as Botox and Botox Cosmetic. The warning says the effects of the botulinum toxin may spread from the area of injection to other areas of the body, causing symptoms similar to those of botulism.
These symptoms can include swallowing and breathing problems. The FDA says it knows of no confirmed cases of the spread of the toxin effect when Botox has been used at the recommended dose to treat chronic migraines, severe underarm sweating, or conditions such as blepharospasm, an involuntary muscle spasm in the muscles surrounding the eyes.
The drug also can cause muscle weakness, double vision, blurred vision, drooping eyelids, loss of bladder control, and hoarseness, Allergan’s statement says.
The same formulation of Botox was approved by the FDA in 2002 for the treatment of facial frown lines.
The FDA says Botox does not appear to be useful in treating or preventing less frequent migraines that occur 14 days or less per month or other forms of headache.